Pfizer

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today

Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the mo

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate

Week in Review: Venture-backed loneliness

Hello everyone and welcome back to Week in Review! Natasha here, subbing in for Lucas while he’s out. This week, we’ll talk about loneliness raising money and how Zoom fatigue is fueling innovatio

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative tre

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 va

Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial

Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that it

Daily Crunch: Apple unveils new Macs

Apple announces “One More Thing” before the holiday season, Uber lets you reserve rides 30 days in advance and Spotify makes another podcast acquisition. This is your Daily Crunch for Nove

Carbon Health raises $100 million with plans to expand pop-up clinics ahead of COVID-19 vaccination programs

Carbon Health has raised a $100 million Series C funding round, led by Dragoneer Investment Group and including participation from prior investors Brookfield Technology Partners, DCVC and Builders VC.

What happens to high-flying startups if the pandemic trade flips?

So much can change in a day. This morning, news that a trial COVID-19 vaccine candidate had an effective rate of more than 90% shook the financial world. The Pfizer vaccine is reportedly so effective,

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial

The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking infection in 90 percent of participants in its Phase 3 clinical trial, the companies announce

The US now seems to be pinning all of its hopes on COVID-19 therapies and vaccines

Almost eight months after the White House first announced it would move from containment to mitigation efforts to stop the spread of the COVID-19 epidemic, the administration is now pinning its hopes

Withings raises $60 million to bridge the gap between consumer tech and healthcare providers

Since being re-acquired from Nokia in 2018 by a group including its original founders and some of its original investors, health tech company Withings has been focused on evolving their offering of co

Digital elective care and telemedicine provider Ro raises $200 million at a reported $1.5 billion valuation

In three years Zachariah Reitano’s startup, Ro, has managed to hit a reported $1.5 billion valuation for its transformation from a company focused on treating erectile dysfunction to a telemedic

Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine

Pharma giant Pfizer announced on Tuesday that it’s working on a potential COVID-19 vaccine with BioNTech, a German company working on new kinds of immunotherapy treatments. The joint effort, con

How healthtech startups can achieve true value

Healthtech is apparently in a golden age. Just a few weeks ago, Livongo and Health Catalyst raised a combined $500 million through IPOs with a joint valuation reaching $3.5 billion...

Drone delivery startup Zipline launches UAV medical program in Ghana

Zipline, the San Francisco-based UAV manufacturer and logistics services provider, has launched a program in Ghana today for drone delivery of medical supplies. Working with the Ghanaian government, Z

Indigo raises $250M, launches marketplace to help farmers get paid for quality grain

Indigo, the startup bringing algorithms and machine learning to the agricultural industry, has raised a $250 million Series E, bringing its total raised to $650 million. The funding values the company

IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics

What happens when you put a technology company together with a drug company and try to come up with unique new ways to understand Parkinson’s disease? You end up with a project that uses sensors